175 related articles for article (PubMed ID: 24426726)
21. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
22. Trends in Gynecologic Carcinosarcoma Based on Analysis of the Surveillance Epidemiology End Result (SEER) Database.
Lee JW; Ouh YT; Chang HK; Min KJ; Lee S; Hong JH; Song JY; Lee JK; Lee NW
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769835
[TBL] [Abstract][Full Text] [Related]
23. Clinico-Pathological Characteristics, Management, and Prognostic Factors of Patients with Uterine Carcinosarcoma: a Retrospective Analysis.
Goyal A; Rajshekar SK; Krishnappa S; Rathod PS; Reddihalli PV; Bafna UD; Kansal Y; Nuthalapati S; Singh A
Indian J Surg Oncol; 2023 Jun; 14(2):466-472. PubMed ID: 37324314
[TBL] [Abstract][Full Text] [Related]
24. [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].
Horn LC; Dallacker M; Bilek K
Pathologe; 2009 Jul; 30(4):292-301. PubMed ID: 19495763
[TBL] [Abstract][Full Text] [Related]
25. Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma.
McEachron J; Heyman T; Shanahan L; Tran V; Friedman M; Gorelick C; Economos K; Singhal PK; Lee YC; Kanis MJ
Int J Gynecol Cancer; 2020 Jul; 30(7):1012-1017. PubMed ID: 32447295
[TBL] [Abstract][Full Text] [Related]
26. Early-stage carcinosarcoma of the uterus: the significance of lymph node count.
Temkin SM; Hellmann M; Lee YC; Abulafia O
Int J Gynecol Cancer; 2007; 17(1):215-9. PubMed ID: 17291256
[TBL] [Abstract][Full Text] [Related]
27. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
28. Carcinosarcoma of the uterus: MRI findings including diffusion-weighted imaging and MR spectroscopy.
Takeuchi M; Matsuzaki K; Harada M
Acta Radiol; 2016 Oct; 57(10):1277-84. PubMed ID: 26787673
[TBL] [Abstract][Full Text] [Related]
29. Carcinosarcoma of the uterine cervix: case report and discussion.
Laterza R; Seveso A; Zefiro F; Formenti G; Mellana L; Donadello N; Ghezzi F; Bolis P; Riva C
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S98-100. PubMed ID: 17727926
[TBL] [Abstract][Full Text] [Related]
30. Uterine Carcinosarcomas - Diagnosis and Management.
Denschlag D; Ulrich UA
Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
[TBL] [Abstract][Full Text] [Related]
31. Carcinosarcomas of the uterus and ovary: a clinicopathologic and immunohistochemical study of 11 cases.
Kondi-Pafiti A; Grapsa D; Hasiakos D; Gennatas K; Fotiou S
Eur J Gynaecol Oncol; 2009; 30(1):93-7. PubMed ID: 19317268
[TBL] [Abstract][Full Text] [Related]
32. Ovarian Carcinosarcoma with Retroperitoneal Para-Aortic Lymph Node Dissemination Followed by an Unusual Postoperative Complication: A Case Report with a Brief Literature Review.
Kostov S; Kornovski Y; Ivanova Y; Dzhenkov D; Stoyanov G; Stoilov S; Slavchev S; Trendafilova E; Yordanov A
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33322259
[No Abstract] [Full Text] [Related]
33. Uterine Sarcoma: The Indian Scenario.
Sivakumari S; Rajaraman R; Subbiah S
Indian J Surg Oncol; 2015 Sep; 6(3):232-6. PubMed ID: 27217670
[TBL] [Abstract][Full Text] [Related]
34. Uterine carcinosarcoma: A review of the literature.
Cantrell LA; Blank SV; Duska LR
Gynecol Oncol; 2015 Jun; 137(3):581-8. PubMed ID: 25805398
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Staging of Uterine Carcinosarcoma Using a Multiquadrant Robotic Platform.
Dellinger TH; Wakabayashi MT; Han ES
J Minim Invasive Gynecol; 2017; 24(4):531-532. PubMed ID: 27794476
[TBL] [Abstract][Full Text] [Related]
36. How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?
Rovirosa A; Ascaso C; Ordi J; Arenas M; Valduvieco I; Lejarcegui JA; Pahisa J; Torne A; Biete A
Clin Transl Oncol; 2009 Oct; 11(10):681-7. PubMed ID: 19828411
[TBL] [Abstract][Full Text] [Related]
37. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
38. The role of lymphadenectomy in uterine leiomyosarcoma: review of the literature and recommendations for the standard surgical procedure.
Dafopoulos A; Tsikouras P; Dimitraki M; Galazios G; Liberis V; Maroulis G; Teichmann AT
Arch Gynecol Obstet; 2010 Sep; 282(3):293-300. PubMed ID: 20502905
[TBL] [Abstract][Full Text] [Related]
39. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K
Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812
[TBL] [Abstract][Full Text] [Related]
40. Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.
Pacaut C; Bourmaud A; Rivoirard R; Moriceau G; Guy JB; Collard O; Bosacki C; Jacquin JP; Levy A; Chauleur C; Magné N; Merrouche Y
Am J Clin Oncol; 2015 Jun; 38(3):272-7. PubMed ID: 23751320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
